Spine surgeons prefer ApiFix® to treat their adolescent patients’ scoliosis
Ted Bird, the Chairman of ApiFix, a commercial-stage company headquartered in Israel that has developed a minimally invasive alternative for treating scoliosis in kids joins eHealth Radio and the Health Care, News & Scoliosis Channels.
Listen to interview with host Eric Michaels and guest Ted Bird discuss the following:
What is Adolescent Idiopathic Scoliosis: AIS?
What is ApiFix? Where is it approved for use?
Why do spine surgeons prefer ApiFix® to treat their adolescent patients’ scoliosis?
Why do adolescent patients prefer that their spine surgeon use ApiFix® to treat their scoliosis?
If we know someone who is going to have scoliosis surgery, what should we tell them about ApiFix®?
Ted Bird is Chairman of ApiFix and Chief Development Officer at the Institute for Applied Neurosciences at the Medical University of South Carolina. One of six siblings, he is the son of the late distinguished neuropathologist, Dr. Edward D. Bird, former Medical Director of Harvard Brain Tissue Resource Center (HBTRC) at McLean Hospital and Professor of Neuropathology at Harvard Medical School. “Dad made a lasting impression on me, that one person can make a big difference in people’s lives. My father’s life work was focused on brain-related hereditary disorders, such as Huntington’s Disease. When I was 10, we moved to the UK, and my father established the world’s first brain tissue bank at Cambridge. Scientists from around the world could study brain-related diseases with specific tissue from my father’s tissue bank. Dad was a role model for the core values of humility, integrity and hard work, and his commitment to patients and their families made me love medicine.”
Ted has nearly 25 years of commercial experience in the spine industry starting in 1991 as Marketing Director with pre-IPO Danek Medical and rising to VP of Marketing, Global Medical Education and Emerging Technologies at Sofamor Danek, which grew from $15 million to $750+ million in annual revenue and was acquired by Medtronic for $3.6 billion in 1999. He subsequently joined DePuy Spine as VP of Strategic Development. Ted also worked for 7 years at Orthofix, ultimately rising to President of the Spine Fixation Division, transforming it from a $15 million operating loss to breakeven in just 18 months, while launching four significant new products. He is especially proud of spearheading the transformation of Orthofix’s acquisition of Blackstone Medical from a distressed entity with declining sales and a questionable reputation into a profitable, integrity-based spinal implant business.